Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical utility of expanded non‐invasive prenatal screening and chromosomal microarray analysis in high‐risk pregnancy

21 Mar 2020

Abstract excerpt

OBJECTIVE: To evaluate the utility of expanded non-invasive prenatal screening (NIPS), compared with chromosomal microarray analysis (CMA), for the detection of chromosomal abnormalities in high-risk pregnancies. METHODS: This was a multicenter retrospective study of singleton pregnancies at high risk for chromosomal abnormality. Patients who underwent expanded NIPS and CMA sequentially during pregnancy from 2015...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomic variations and chromosomal abnormalities
Share to Gestational Trophoblastic Disease Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32198896
DOI: 10.1002/uog.22021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical utility of expanded non‐invasive prenatal screening and chromosomal microarray analysis in high‐risk pregnancyPMID 32198896Read ↗

Expanded non-invasive prenatal testing offers better detection of fetal copy number variations but not chromosomal aneuploidiesSemantic proximity Read ↗

Clinical Application of Chromosomal Microarray Analysis in High-Risk PregnanciesSemantic proximity Read ↗

Prenatal Diagnosis Using Chromosomal Microarray Analysis in High-Risk PregnanciesSemantic proximity Read ↗

Clinical experience of genome-wide non-invasive prenatal testing as a first-tier screening test in a cohort of 59,771 pregnanciesSemantic proximity Read ↗

Clinical application of expanded noninvasive prenatal testing for fetal chromosome abnormalities in a cohort of 39,580 pregnanciesSemantic proximity Read ↗

Performance of expanded non-invasive prenatal testing for fetal aneuploidies and copy number variations: A prospective study from a single center in Jiangxi province, ChinaSemantic proximity Read ↗

A retrospective study for diagnostic value of chromosomal microarray analysis in fetuses with high-risk prenatal indicationsSemantic proximity Read ↗

The Clinical Application of Non-invasive Prenatal Genetic Testing in the Screening of Fetal Chromosomal DiseasesSemantic proximity Read ↗

The role of non-invasive prenatal testing and ultrasound in prenatal screening of fetal chromosomal abnormalities in singleton: a retrospective studySemantic proximity Read ↗

Social and medical need for whole genome high resolution NIPTSemantic proximity Read ↗

Efficiency of expanded noninvasive prenatal testing in the detection of fetal subchromosomal microdeletion and microduplication in a cohort of 31,256 single pregnanciesSemantic proximity Read ↗

Expanded noninvasive prenatal testing for fetal aneuploidy and copy number variations and parental willingness for invasive diagnosis in a cohort of 18,516 casesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.